In addition, inhibition of miR-33-5p lowered the endogenous cortical level of amyloid-β in a mouse model of Alzheimer’s disease (AD) via increased ABCA1 expression and APOE lipidation, suggesting a potential therapeutic strategy for AD32. The gene discussed is APOE; the disease is Alzheimer disease.